Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
bwolfy2002's Profile
Displaying 801-820 of 820 result(s).
GNBTQ Generex Biotechnology Corp.
11/15/2019 7:35:55 PM
Fidelity does, you can get it free
GNBTQ Generex Biotechnology Corp.
11/15/2019 1:25:59 PM
I noticed this as well, but it did (1)
GNBTQ Generex Biotechnology Corp.
11/15/2019 1:18:49 PM
You know what they say about assumi
GNBTQ Generex Biotechnology Corp.
11/15/2019 1:09:39 PM
The SP has not dropped yet by the e (1)
GNBTQ Generex Biotechnology Corp.
11/15/2019 12:38:27 PM
What is unclear and the two of you
CYDY CytoDyn Inc
11/14/2019 4:01:14 PM
He said $5mm-$7mm IF we get licensi (1)
GNBTQ Generex Biotechnology Corp.
11/13/2019 2:46:14 PM
Sure, I imagine it’s still unclea
GNBTQ Generex Biotechnology Corp.
11/13/2019 2:37:47 PM
Yes, Joe said as much last call tha
GNBTQ Generex Biotechnology Corp.
11/13/2019 2:25:35 PM
What do you mean this is not helpfu
CYDY CytoDyn Inc
11/13/2019 11:30:25 AM
Everyone keeps talking about a vide
GNBTQ Generex Biotechnology Corp.
11/12/2019 5:47:11 PM
Thx PJ and Hy. (1)
GNBTQ Generex Biotechnology Corp.
11/12/2019 5:38:07 PM
Benefit how? I don’t mean rising
GNBTQ Generex Biotechnology Corp.
11/12/2019 5:15:19 PM
Can anyone comment on NGIO value fo (1)
GNBTQ Generex Biotechnology Corp.
11/12/2019 1:24:53 PM
I have a simple question: on the 10
GNBTQ Generex Biotechnology Corp.
11/12/2019 9:56:16 AM
So it’s short of $2mm... (1)
GNBTQ Generex Biotechnology Corp.
11/11/2019 5:33:34 PM
Ok, that is a succinct post to my r
GNBTQ Generex Biotechnology Corp.
11/11/2019 5:21:24 PM
Yes, curious about that timeline. W
GNBTQ Generex Biotechnology Corp.
11/11/2019 3:48:53 PM
Even a proportional drop instead of
CYDY CytoDyn Inc
11/11/2019 11:03:11 AM
Well, moot now as it’s lower than
CYDY CytoDyn Inc
11/11/2019 10:52:26 AM
It’s odd, it doesn’t show it as
Go to page:
  • << First
  • < Previous
  • 16
  • 17
  • Next >

Recent Articles

  • Trump Engages TikTok Advocating Accountability for Media
  • Understanding Economic Inequality Through Robert Reich's Lens
  • Rent Surges in NYC’s Top Neighborhoods Amid Economic Shifts
  • Navigating Investor Rights: Semler Scientific Case Update
  • Trump Intensifies Rhetoric Against Soros Amid Controversy
  • Breast Cancer Antibody Drug Conjugates: Opportunities Ahead
  • Important Update for SelectQuote, Inc. Investors on Class Action
  • Cornelius D. Jones Joins Prestigious Academy of Authors
  • Lantheus Holdings Faces Class Action: Investors Urged to Act
  • Hyundai's Supernal Faces Leadership Changes, Future Uncertain
  • Larry Ellison: From College Dropout to Tech Titan
  • Gold Producers Tackle Emissions with Mixed Results in ESG Metrics
  • China's Potential Ban on Flush Door Handles in Cars
  • Market Insights: Top 10 Large Cap Stocks Facing Declines
  • Crypto Landscape Shifts: Ethereum ETFs Surge Amid Market Changes
  • Investigating PACS Group, Inc.: Shareholder Concerns Addressed
  • Pomerantz Law Firm Launches Investigation on Freeport-McMoRan
  • Quanex Building Products Faces Potential Investor Claims Today
  • Geely Automobile Holdings: Investor Concerns and Legal Steps
  • MarineMax, Inc. Investors: Key Insights and Updates for HZO
  • Matrix Service Company Faces Scrutiny Over Investor Claims
  • Pomerantz Law Firm Investigates Potential Securities Fraud by BellRing Brands
  • Bumble Inc. Faces Legal Scrutiny Over Potential Securities Violations
  • Pomerantz Law Firm Launches Investigation into Agilon Health
  • Pomerantz Law Firm Reviews Securities Claims Against Synopsys
  • Investor Investigation: Duolingo, Inc. Faces Claims and Trends
  • Insperity, Inc. Under Investigation for Possible Securities Fraud
  • Class Action Filed Against Dow Inc. by Pomerantz Law Firm
  • Concerns Rise as Pomerantz Law Firm Investigates Fluor Corp
  • Big Week for Large-Cap Stocks: Top Gainers You Can't Miss
  • Celebrating Everlight Solar: Madison's Top Choice in 2025
  • Invest in Capricor Therapeutics: Upcoming Class Action Deadline
  • California's AI Safety Bill Awaits Final Authoritative Approval
  • Elon Musk Presses Microsoft CEO on Activision Blizzard Remarks
  • Optimove Leads with Innovative Solutions for iGaming Growth
  • Exploring America’s Race to Artificial Superintelligence
  • How Buck Sexton Highlights Leadership in the AI Arms Race
  • Elevate Your Skills: Join PayrollOrg’s Leadership Conference
  • Celebrating Fashion: A Night of Style With Calvin Klein
  • Recent Crypto Trends: Silver Surges and Dogecoin's Rise
  • Political Charges and Market Movements: A Crypto Perspective
  • Fangzhou's Innovative AI Technology Revolutionizes Health Care
  • Investigation into Lantheus Holdings by Securities Law Firm
  • Monopar Therapeutics Reveals Promising ALXN1840 Findings
  • Weekly Highlights in Mobility: EV Sales Surge and Uber Lawsuit
  • HKUST Strengthens Global Innovation Ties with Sweden
  • Monopar Showcasing Promising Long-Term Data for ALXN1840
  • Market Insights: iPhone 17 Unveiling and AI Growth Trends
  • Explore Dubai Effortlessly: Thrivestate's Unique Program
  • Court Deadline Approaches for RxSight Investors Amid Revelations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site